The chicken retrovirus-like gene ENS-1/ERNI and Soprano LTR are involved in primordial germ cell development Authors: Yuya Okuzaki, Akane Kawaguchi, Yumi Ozaki, Takeo Uemura, Daisuke Saito, Ken-ichi Nishijima Published: 2026 ABSTRACT SummaryCultured chicken primordial germ cells (PGCs) are vital for reproductive biology and genetic preservation; however, establishing stable lines from certain breeds or female embryos remains challenging. We herein demonstrated that the expression of the Galliformes-specific retrovirus-like gene ENS-1/ERNI correlated with PGC line establishment efficiency. CRISPRi targeting its LTR sequence (Soprano) down-regulated homeostasis-related gene expression. These PGCs exhibited abnormal cell-cycle arrest and reduced proliferation under DNA damage, as well as impaired colonization of the genital ridges upon transplantation. Our results suggest the involvement of Soprano LTR and ENS-1/ERNI in the development of chicken PGCs and their adaptation to the in vitro environment. Introduction Primordial germ cells (PGCs) are specialized stem cells in animal embryonic development: they are the sole precursors to gametes, responsible for transmitting genetic information to subsequent generations. Although the mechanisms underlying these developmental processes are important issues in developmental and reproductive biology, knowledge remains limited for species other than rodents and humans. Chickens are among the most widely raised livestock in the world, with numerous regionally specific breeds. The preservation of these breeds is crucial for genetic diversity and agricultural purposes; however, the cryopreservation of fertilized eggs, a standard method in mammals, is challenging in avian species due to the presence of large yolks and eggshells. Therefore, avian PGCs represent an attractive alternative for preserving genetic resources. Recent extensive research on birds has enabled long-term in vitro PGC cultures without the loss of their capacity to differentiate into sperm and oocytes upon transplantation into recipient embryos.1,2,3,4 This technology enables both the cryopreservation of genetic resources and the creation of genetically modified chickens.5,6,7,8,9,10 Furthermore, the availability of long-term culture systems makes chicken PGCs an excellent model for studying germ cell development. However, stable PGC cultivation remains difficult for certain breeds and female-derived embryos, and the molecular and cellular mechanisms governing PGC expansion and development remain unclear.1,3,4,11,12,13,14 Therefore, further analyses of chicken PGCs are essential for both fundamental reproductive biology and the practical conservation and modification of avian genetic resources in agriculture. Transposable elements (TEs), also known as jumping genes, are genetic elements that are capable of relocating their sequences within a genome. Recent studies demonstrated that TEs are not merely selfish parasitic sequences, they are also involved in various physiological processes, including germ cell and embryonic development, as well as oncogenesis.15,16 Among various TEs, long terminal repeat (LTR) retrotransposons are considered to have shared a common ancestor with retroviruses early in vertebrate evolution.17 Functional LTR retrotransposons encode viral Gag, Pol, and Env genes. Some of these have co-evolved with host genes and become involved in mammalian embryonic development, such as Syncytin-1 and PEG10.15,16,18,19 Furthermore, LTR sequences distributed throughout the genome often function as cis-regulatory elements, such as promoters and enhancers, thereby affecting gene expression across various cell types.20,21 Notably, birds possess a significantly lower percentage of TEs in their genome than mammals and reptiles; however, they harbor several families of LTR transposons.22 In chickens, four main types of LTR retrotransposons (Birddawg, Hitchcock, Kronos, and Soprano) have been identified.23 Of these, Soprano exists in more than 1,000 copies in the chicken genome; most are solo LTRs or truncated sequences lacking functional coding sequences. However, some Soprano contains ENS-1 and ERNI as internal domains, which encode functional proteins distinct from Gag, Pol, and Env. ENS-1/ERNI is a Galliformes-specific endogenous retrovirus-like gene that was originally reported to be expressed in prospective neural plates and the area pellucida of blastoderms.24 Subsequent studies showed that it was also expressed in the hypoblast, the pluripotent epiblast, PGCs, embryonic gonads and in embryonic stem cells established from the pluripotent epiblast.25,26,27,28,29,30 While the ENS-1/ERNI protein plays a key role in neural plate development by regulating the timing of SOX2 expression together with the epigenetic regulator CBX3 (also known as HP1γ),26 its role in other cell types including PGCs and the function of solo Soprano LTRs remain unclear. We herein performed a transcriptome analysis of cultured PGCs from chicken breeds with different cultured PGC establishment efficiencies (EEs) and found that ENS-1/ERNI expression correlated with EE. Furthermore, we demonstrated that ENS-1/ERNI and Soprano were associated with broad changes in cell homeostasis-related gene expression and cell cycle progression in cultured PGCs and were involved in the early development of PGCs in ovo. Collectively, this study sheds new light on the role of LTR retrotransposons in the development of germ cells in birds. Results Establishment of in vitro-cultured PGCs from various chicken strains During the course of efforts to cryopreserve various chicken breeds maintained at the Avian Bioscience Research Center, Nagoya University,31 we attempted to establish in vitro cultured PGC lines from various inbred or closed chicken strains. The established cell lines expressed PGC marker genes at comparable levels to those of in vivo PGCs (Figure S1A),1,32,33,34 and retained the ability to produce offspring, as confirmed by transplantation experiments using cultured PGCs from several strains (GSP, GSN/1, and M/O; Figure S1B; Table S1).31 On the other hand, EE markedly varied depending on the strain, as shown along with the sex of cultured PGCs in Table 1. Consistent with previous findings,1,13 the establishment of female PGC lines was more difficult in strains with low EE (Figure 1A). Furthermore, we noted that strains with low EE, as well as female PGCs, generally exhibited slower proliferation rates during the establishment process (Figures S2A and S2B).Table 1The establishment efficiency of in vitro cultured PGC lines from various chicken strainsChicken strainsGroupSeeded numberSeeded numberEstablished numberEstablished numberEstablishment efficiencyEstablishment efficiencyEstablishment efficiencyCulture day for establishment (average day ± SD)Culture day for establishment (average day ± SD)Culture day for establishment (average day ± SD)––MaleFemaleMaleFemaleTotalMaleFemaleTotalMaleFemaleGSN/1 (Fayoumi breed)Fayoumi172411100.510.650.4234.4±17.132.6±15.136.4±19.4PNP (Fayoumi breed)Fayoumi44421650.240.360.1234.2±9.934.6±8.832.5±14.9GSP (Fayoumi breed)Fayoumi37481080.210.270.1737±11.341.0±13.031.7±7.6WLG (White Leghorn breed)European11101070.810.910.7025.8±7.324.7±3.827.8±11.5M/O (White Leghorn breed)European7197191.001.001.0018.8±2.618.1±1.919.1±2.9BLE (Brown Leghorn breed)European151315110.931.000.8523.9±7.119.8±2.029.5±7.7GB (Game Bantam breed)European1119670.430.550.3720.6±4.118.8±4.022.2±3.8OSEuropean3433810.130.240.0334.9±14.533.9±15.442.0DD (Dandarawi breed)European293418190.590.620.5627.9±6.326.1±4.930±7.1BMC (Black Minorca breed)European321816120.560.500.6733.8±9.432.5±9.735.4±9.2POL (Polish breed)European88780.940.881.0021.8±5.520.0±2.422.9±6.7BRB (Brahma Bamtam breed)European1713640.330.350.3130.6±7.926.7±3.938.3±8.7PC (Petit-Cocco breed)Asian171615120.820.880.7526.5±7.022.4±4.231.5±6.6JB (Japanese Bantam breed)Asian293716110.410.550.3026.7±14.222.9±9.632.4±18.0EJ (Ehime-Jidori breed)Asian85751560.130.180.0831.0±9.130.3±9.041.0±0.0SIL (White Silkie breed)Asian915870.630.890.4728.1±13.125.8±9.431.2±9.4CHN (Okinawa Crower breed)Asian1017760.480.700.3531.4±15.024.4±17.839.5±17.8CB (Cochin Bantam breed)Asian4652430.070.090.0631.6±8.730.0±12.234.3±12.2NGY (Nagoya breed)Asian20281370.420.650.2527.3±4.728.3±2.025.3±2.0KS (Ko-Shamo breed)Asian2225770.300.320.2827.6±9.428.0±9.327.3±9.3CAL (White Wyandotte breed)European x Asian25221260.380.480.2738.5±12.934.3±16.847±16.8TKFayoumi x Asian201419140.970.951.0029.5±11.226.1±12.434.1±12.4GRNN/A27181670.510.590.3932.6±14.429.3±20.540.7±20.5The grouping of each chicken strain is based on a phylogenetic tree analysis using microsatellite markers by Nunome et al.35Figure 1The retrovirus-like gene ENS-1/ERNI shows high levels of expression in cultured PGCs and correlates with EE(A) Correlation between the EE and sex ratio of in vitro cultured PGCs. Symbols in the legend indicate different types of chicken breeds. R represents Pearson’s correlation coefficient. EE and sex ratio values for each chicken strain are summarized in Table 1.(B) Venn diagram showing the overlap among three DEG datasets: (i) common DEGs in male PGCs from M/O (three biological replicates) vs. Fayoumi GSP, GSN/1, and PNP strains (three biological replicates each) (padj <0.01), (ii) common DEGs in female PGCs from M/O (three biological replicates) vs. the three other Fayoumi strains (three biological replicates each) (padj <0.01), and (iii) DEGs up-regulated in M/O cultured PGCs (six biological replicates: three male and three female) relative to M/O CEFs (four biological replicates: two male and two female) (padj <0.01, FC > 2).(C) ENS-1 and ERNI expression levels in in ovo PGCs at various embryonic stages, based on an RNA-seq re-analysis.36 Data represent the mean ± SD of four biological replicates. ∗∗∗∗p < 0.0001, ns: not significant; a one-way ANOVA followed by Tukey’s post hoc test.(D) Correlation between the EE of in vitro cultured PGCs and the mean expression levels of ENS-1/ERNI. Expression was evaluated for individual clones by RT-qPCR and normalized to GAPDH. Data represent the mean ± SD of six biological replicates for each strain, except for the PNP strain (n = 4). Symbols in the legend indicate the type of chicken breed. R represents Pearson’s correlation coefficient. Note: The primers used in RT-qPCR do not distinguish between ENS-1 and ERNI.(E) A RT-qPCR analysis of ENS-1/ERNI and the UTR of Soprano using RNA from M/O strain in vitro cultured PGCs and in ovo PGCs collected from E2.5 embryonic blood. Expression levels were normalized to GAPDH. Data represent the mean ± SD of four (in ovo PGCs) and six (cultured PGCs) biological replicates. ∗p < 0.05; the Student’s t test. Table 1The establishment efficiency of in vitro cultured PGC lines from various chicken strainsChicken strainsGroupSeeded numberSeeded numberEstablished numberEstablished numberEstablishment efficiencyEstablishment efficiencyEstablishment efficiencyCulture day for establishment (average day ± SD)Culture day for establishment (average day ± SD)Culture day for establishment (average day ± SD)––MaleFemaleMaleFemaleTotalMaleFemaleTotalMaleFemaleGSN/1 (Fayoumi breed)Fayoumi172411100.510.650.4234.4±17.132.6±15.136.4±19.4PNP (Fayoumi breed)Fayoumi44421650.240.360.1234.2±9.934.6±8.832.5±14.9GSP (Fayoumi breed)Fayoumi37481080.210.270.1737±11.341.0±13.031.7±7.6WLG (White Leghorn breed)European11101070.810.910.7025.8±7.324.7±3.827.8±11.5M/O (White Leghorn breed)European7197191.001.001.0018.8±2.618.1±1.919.1±2.9BLE (Brown Leghorn breed)European151315110.931.000.8523.9±7.119.8±2.029.5±7.7GB (Game Bantam breed)European1119670.430.550.3720.6±4.118.8±4.022.2±3.8OSEuropean3433810.130.240.0334.9±14.533.9±15.442.0DD (Dandarawi breed)European293418190.590.620.5627.9±6.326.1±4.930±7.1BMC (Black Minorca breed)European321816120.560.500.6733.8±9.432.5±9.735.4±9.2POL (Polish breed)European88780.940.881.0021.8±5.520.0±2.422.9±6.7BRB (Brahma Bamtam breed)European1713640.330.350.3130.6±7.926.7±3.938.3±8.7PC (Petit-Cocco breed)Asian171615120.820.880.7526.5±7.022.4±4.231.5±6.6JB (Japanese Bantam breed)Asian293716110.410.550.3026.7±14.222.9±9.632.4±18.0EJ (Ehime-Jidori breed)Asian85751560.130.180.0831.0±9.130.3±9.041.0±0.0SIL (White Silkie breed)Asian915870.630.890.4728.1±13.125.8±9.431.2±9.4CHN (Okinawa Crower breed)Asian1017760.480.700.3531.4±15.024.4±17.839.5±17.8CB (Cochin Bantam breed)Asian4652430.070.090.0631.6±8.730.0±12.234.3±12.2NGY (Nagoya breed)Asian20281370.420.650.2527.3±4.728.3±2.025.3±2.0KS (Ko-Shamo breed)Asian2225770.300.320.2827.6±9.428.0±9.327.3±9.3CAL (White Wyandotte breed)European x Asian25221260.380.480.2738.5±12.934.3±16.847±16.8TKFayoumi x Asian201419140.970.951.0029.5±11.226.1±12.434.1±12.4GRNN/A27181670.510.590.3932.6±14.429.3±20.540.7±20.5The grouping of each chicken strain is based on a phylogenetic tree analysis using microsatellite markers by Nunome et al.35 The establishment efficiency of in vitro cultured PGC lines from various chicken strains The grouping of each chicken strain is based on a phylogenetic tree analysis using microsatellite markers by Nunome et al.35 The retrovirus-like gene ENS-1/ERNI shows high levels of expression in cultured PGCs and correlates with EE (A) Correlation between the EE and sex ratio of in vitro cultured PGCs. Symbols in the legend indicate different types of chicken breeds. R represents Pearson’s correlation coefficient. EE and sex ratio values for each chicken strain are summarized in Table 1. (B) Venn diagram showing the overlap among three DEG datasets: (i) common DEGs in male PGCs from M/O (three biological replicates) vs. Fayoumi GSP, GSN/1, and PNP strains (three biological replicates each) (padj <0.01), (ii) common DEGs in female PGCs from M/O (three biological replicates) vs. the three other Fayoumi strains (three biological replicates each) (padj <0.01), and (iii) DEGs up-regulated in M/O cultured PGCs (six biological replicates: three male and three female) relative to M/O CEFs (four biological replicates: two male and two female) (padj <0.01, FC > 2). (C) ENS-1 and ERNI expression levels in in ovo PGCs at various embryonic stages, based on an RNA-seq re-analysis.36 Data represent the mean ± SD of four biological replicates. ∗∗∗∗p < 0.0001, ns: not significant; a one-way ANOVA followed by Tukey’s post hoc test. (D) Correlation between the EE of in vitro cultured PGCs and the mean expression levels of ENS-1/ERNI. Expression was evaluated for individual clones by RT-qPCR and normalized to GAPDH. Data represent the mean ± SD of six biological replicates for each strain, except for the PNP strain (n = 4). Symbols in the legend indicate the type of chicken breed. R represents Pearson’s correlation coefficient. Note: The primers used in RT-qPCR do not distinguish between ENS-1 and ERNI. (E) A RT-qPCR analysis of ENS-1/ERNI and the UTR of Soprano using RNA from M/O strain in vitro cultured PGCs and in ovo PGCs collected from E2.5 embryonic blood. Expression levels were normalized to GAPDH. Data represent the mean ± SD of four (in ovo PGCs) and six (cultured PGCs) biological replicates. ∗p < 0.05; the Student’s t test. ENS-1/ERNI expression levels correlate with the EE of in vitro-cultured PGCs To elucidate the mechanisms underlying sex- and strain-specific differences in the EE of cultured PGCs, we performed an RNA-seq analysis of male and female PGC lines derived from several chicken strains. These included three strains of the Fayoumi breed (GSP, GSN/1, and PNP), which exhibited varying degrees of low EE, and the M/O strain of the White Leghorn breed, which showed the highest EE among the strains tested. Although EE markedly differed between male and female PGCs (Table 1; Figure 1A), the overall number of differentially expressed genes (DEGs) were relatively small when the four strains were analyzed together (655 genes, padj <0.01; and 255 genes, padj <0.01, |Fold Change [FC]| > 2; Figure S3A, Table S2). Very few DEGs were common across all strains (28 genes, padj <0.01), and most of these were female-specific genes located on the W chromosome (Figure S3B; Table S3). In contrast, a larger number of DEGs between the sexes was observed within each specific strain, which suggests that the sex-dependent DEGs of cultured PGCs may be largely affected by the genetic background of each strain, rather than being a universal trait across the strains. Consistent with previous reports showing no chromosome-wide dosage compensation in birds,37,38 the present results demonstrated that Z-linked gene expression was nearly 2-fold higher in males than in females (median, 1.74), except for a subset of genes (Figures S3C and S3D). Recent studies indicate that while Z-linked genes are up-regulated at the transcriptional and translational levels in females, their expression in males is suppressed by miRNA-mediated transcript degradation.39 Our results align with these mechanisms, suggesting that the dosage balance in chicken PGCs is maintained through gene-specific regulation rather than a uniform chromosome-wide system, as previously discussed.14,37,38,39,40 Regarding strain-specific transcriptome differences, we identified 3,691 and 1,768 DEGs in male and female PGCs, respectively, showing significant expression variance among the four strains (padj <0.01) (Table S4). Among these, 1,221 DEGs were shared between the two sexes. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of these common genes consistently highlighted calcium signaling and neurogenesis (Figures S3E and S3F; Table S5). Notably, calcium signaling emerged as a predominant term in both analyses, including the KEGG “Calcium signaling pathway” and various GO molecular function (MF) terms related to ion channels and transmembrane transporters. Cultured PGCs are highly sensitive to calcium ion concentrations and require a specialized medium with reduced calcium levels to prevent cell-cell aggregation.1 These strain-specific differences in calcium dynamics align with our observations that the degree of PGC aggregation varies among strains. To clarify the differences in EE among strains, we further analyzed DEGs between the M/O strain and the three Fayoumi breeds. We identified 602 male and 329 female DEGs (padj <0.01) showing significant expression variance in the M/O strain relative to all Fayoumi breeds (Figure S3G; Table S6). Among these, 161 DEGs was shared between the two sexes. Since GO and KEGG pathway enrichment analyses yielded no characteristic functional clusters for these genes, we focused on those specifically expressed in PGCs. By comparing the transcriptome of M/O PGCs with that of chicken embryonic fibroblasts (CEFs), a somatic cell control, we extracted 83 M/O PGC-specific DEGs (Figure 1B; Table S7). ERNI emerged as the top-hit gene, exhibiting its highest expression in the M/O strain and significantly lower levels in the Fayoumi breeds. A re-analysis of RNA-seq data from endogenous, non-cultured in ovo PGCs (Ichikawa et al.36) revealed that ERNI and ENS-1 were highly expressed in blood-circulating PGCs at E2.5; however, their expression decreased after PGCs settled into the genital ridge (Figure 1C). Nevertheless, a certain level of ENS-1/ERNI expression was maintained in gonadal PGCs at E6.5.41 A RT-qPCR analysis confirmed that ENS-1/ERNI was expressed in cultured PGCs established from various chicken strains, with expression levels varying among strains, which was consistent with RNA-seq results. Furthermore, a moderate correlation was observed between ENS-1/ERNI expression levels and both EE and the culture days required for establishment (Figures 1D and S3H). Moreover, the expression of ENS-1/ERNI and the UTR in the Soprano LTR was higher in cultured PGCs than in E2.5 blood-circulating in ovo PGCs (Figure 1E). Regulation of gene expression in cultured PGCs by ENS-1/ERNI and the Soprano LTR ENS-1/ERNI is highly expressed in early-stage in vivo PGCs and in cultured PGC lines with high EE. Given these observations, we hypothesized that ENS-1/ERNI is involved in in vivo PGC development as well as in the in vitro expansion or functional maintenance of cultured PGCs. ENS-1/ERNI is an endogenous retrovirus-like gene, and its LTR, Soprano, exists in more than 1,000 copies within the chicken genome,23 along with dozens of truncated ENS-1/ERNI pseudogenes.26 To investigate the collective function of these repetitive elements rather than targeting individual loci, we employed CRISPRi to suppress the Soprano LTR. We established a PGC line stably expressing dCas9-KRAB-MeCP2 (CRISPRi PGCs),42 and induced CRISPRi by transfecting these cells with in vitro synthesized sgRNAs targeting the Soprano LTR (Figure S4A). Although the RNA-seq analysis revealed only a moderate decrease in ENS-1/ERNI expression, potentially due to low sgRNA stability, significant transcriptomic changes were observed. Specifically, 256 and 248 genes were differentially expressed in sgSoprano#1 and sgSoprano#2, respectively (padj <0.05, |FC| > 1.5; Figure S4B; Tables S8 and S9). To enhance CRISPRi efficiency against the Soprano LTR, we constructed a plasmid expressing three different sgRNAs (3× sgSoprano; Figure S4A). This vector successfully suppressed the expression of ENS-1/ERNI to less than 9% and 5% of control levels, respectively, and also reduced the expression of many ENS-1/ERNI-like pseudogenes (Figure 2A; Table S10). Furthermore, an immunofluorescence (IF) analysis confirmed a corresponding reduction in ENS-1/ERNI at the protein level (Figure S4C). A transcriptomic analysis identified 1,422 DEGs (padj <0.01), with 307 genes showing a fold-change greater than two (padj <0.01, |FC| > 2). GO and KEGG pathway analyses both indicated that Soprano LTR suppression down-regulated genes associated with ribosomes, the endoplasmic reticulum, and oxidative phosphorylation, suggesting that suppression of the Soprano LTR was associated with broad changes in metabolic gene expression in cultured PGCs (Figures 2B and S4D; Tables S11 and S12). Conversely, genes related to cell adhesion and motility were significantly up-regulated in both analyses, with GO terms further highlighting nervous system development, which is consistent with our strain-specific GO and KEGG results. Furthermore, the prominence of GO terms related to nervous system development aligns with previous studies reporting ENS-1/ERNI involvement in neural cell differentiation.24,25,26 A total of 199 DEGs (padj <0.05) were shared across the three different Soprano LTR CRISPRi conditions (Figure S4E). Among the 25 DEGs identified in 3× sgSoprano plasmid-transfected samples (padj <0.05, |FC| > 2; Table S13), 11 were protein-coding genes: AGK, CDH7, DENND11, ENOX1, GUCA1C, SLC16A7, TMPRSS15, LOC418414, WEE2, ENS-1, and ERNI. Regarding CDH7, SLC16A7, and TMPRSS15, Soprano-like sequences were identified within their 500-kb flanking regions (Figure S4F), suggesting the possible regulation of these genes by the enhancer activity of the Soprano LTR. Notably, several genes were organized in genomic clusters: AGK/DENND11/WEE2 and GUCA1C/LOC418414 were located within narrow regions (within 70-kb and 110-kb regions on Chr 1, respectively), although a BLAST analysis detected no Soprano-like sequences within 500 kb of these clusters. The RT-qPCR analysis confirmed the down-regulation of these genes in cultured PGCs under Soprano LTR CRISPRi conditions, consistent with RNA-seq data, with the exception of DENND11 (Figure 2C). Due to the limited availability of chicken-reactive antibodies for these genes, we selected CDH7 as a representative for protein-level validation; the IF analysis confirmed a reduction in CDH7 expression in these cells (Figure S4G). A detailed examination of DENND11 mapped reads revealed that unspliced RNA was transcribed in control (3× sgOVA) samples (Figure S4H). A strand-specific read count analysis further suggested that this long non-coding RNA was expressed from the reverse strand of DENND11 (Figure S4I). Collectively, these results suggest that transcription from the positive strand of the AGK/DENND11/WEE2 locus was activated by Soprano activity in cultured PGCs; conversely, Soprano repression reduced positive-strand transcription while increasing DENND11 coding antisense transcription. Furthermore, a re-analysis of embryonic PGC RNA-seq data36 showed that most of these genes were highly expressed in E2.5 embryonic PGCs, with expression levels typically declining in subsequent stages, except for ENOX1, LOC418414, and TMPRSS15 (Figure S4J). This pattern aligns with the developmental decline in ENS-1/ERNI expression.Figure 2Changes in gene expression in cultured PGCs under Soprano LTR CRISPRi(A) Volcano plot showing DEGs identified between 3× sgSoprano- and 3× sgOVA- (control) transfected CRISPRi PGCs. Dashed lines indicate the –Log10 padj >2 and |Log2 FC| > 1 thresholds.Data from three biological replicates are shown.(B) GO analyses of DEGs (padj <0.01) identified between 3× sgSoprano- and 3× sgOVA- (control) transfected CRISPRi PGCs. The upper and lower figures show significantly enriched GO terms for down- and up-regulated genes under 3× sgSoprano conditions, respectively. Data from three biological replicates are shown.(C) Effects of Soprano LTR CRISPRi on target gene expression.CRISPRi PGCs were transfected with 3× sgOVA or 3× sgSoprano expression plasmids, and gene expression was analyzed by RT-qPCR. Expression levels were normalized to GAPDH, with the 3× sgOVA control group set to 1.Data represent the mean ± SD of four biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; the Student’s t test. Changes in gene expression in cultured PGCs under Soprano LTR CRISPRi (A) Volcano plot showing DEGs identified between 3× sgSoprano- and 3× sgOVA- (control) transfected CRISPRi PGCs. Dashed lines indicate the –Log10 padj >2 and |Log2 FC| > 1 thresholds. Data from three biological replicates are shown. (B) GO analyses of DEGs (padj <0.01) identified between 3× sgSoprano- and 3× sgOVA- (control) transfected CRISPRi PGCs. The upper and lower figures show significantly enriched GO terms for down- and up-regulated genes under 3× sgSoprano conditions, respectively. Data from three biological replicates are shown. (C) Effects of Soprano LTR CRISPRi on target gene expression. CRISPRi PGCs were transfected with 3× sgOVA or 3× sgSoprano expression plasmids, and gene expression was analyzed by RT-qPCR. Expression levels were normalized to GAPDH, with the 3× sgOVA control group set to 1. Data represent the mean ± SD of four biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; the Student’s t test. To clarify whether these results were due to the ENS-1/ERNI protein and/or Soprano, we performed CRISPR-Cas9-mediated knockout experiments. We designed three different sgRNAs targeting the ENS-1/ERNI coding region and transfected cultured PGCs with Cas9 and sgRNA expression plasmids (Figure S5A). An analysis of knockout efficiency in bulk PGCs revealed varying indel induction rates among these sgRNAs, ranging from 4% to 48% (Figure S5B). Nevertheless, following the transient selection of transfected PGCs, we observed a consistent and gradual decrease in cell numbers across all sgRNA treatments (Figure S5C). Since the chicken genome contains dozens of ENS-1/ERNI-like pseudogene sequences,25,27 we attributed this growth inhibition to a DNA damage response triggered by Cas9-induced genomic breaks, rather than the loss of ENS-1/ERNI function itself. Therefore, to avoid the potential confounding effects of DNA damage associated with CRISPR-Cas9, we performed the siRNA-mediated knockdown of ENS-1/ERNI in cultured PGCs. We designed two siRNAs targeting the ENS-1/ERNI coding region (#1 targeting the central region and #2 targeting the 3′ terminal region, Figure S5A). Both siRNAs successfully reduced ENS-1/ERNI expression by approximately 50%–70%, with a concomitant reduction in the expression of the UTR within the Soprano LTR. Notably, genes that were down-regulated by Soprano LTR CRISPRi also showed modest, but significant decreases following the knockdown of ENS-1/ERNI (Figure 3A). Similar results were observed in PGCs derived from the GSP strain, which expresses lower endogenous levels of ENS-1/ERNI (Figure S6). We then performed ENS-1/ERNI rescue experiments using CRISPRi PGCs. Due to the inherently high expression of ENS-1/ERNI in cultured PGCs, the transient transfection of an ERNI expression vector failed to achieve similar expression levels to endogenous control levels (Figure 3B). However, the RT-qPCR analysis showed that WEE2 expression was partially restored by a similar magnitude to ERNI expression. Furthermore, DENND11 expression was further increased by ERNI under Soprano LTR CRISPRi conditions. In contrast, the expression of other genes was not rescued, suggesting that their regulation required Soprano activity and/or higher levels of ERNI expression. Taken together with RNA-seq results, in the AGK/DENND11/WEE2 locus, Soprano activity was associated with increased WEE2 expression and reduced DENND11 expression, whereas ERNI slightly up-regulated both genes. Collectively, these results suggest the partial involvement of ENS-1/ERNI in the regulation of these target genes, and also that Soprano and ENS-1/ERNI modulate gene expression through partially distinct mechanisms, although they may affect one another.Figure 3ENS-1/ERNI regulates the expression of genes affected by Soprano LTR CRISPRi(A) ENS-1/ERNI knockdown experiments. Cultured PGCs were transfected with DsiRNA, and gene expression was analyzed by RT-qPCR. Expression levels were normalized to GAPDH, with the control DsiRNA group set to 1. Data represent the mean ± SD of three biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; a one-way ANOVA followed by Dunnett’s post hoc test.(B) ENS-1/ERNI rescue experiments. CRISPRi PGCs were co-transfected with an ERNI expression plasmid and either 3× sgSoprano or 3× sgOVA expression plasmids. Gene expression was analyzed by RT-qPCR and normalized to GAPDH, with the 3× sgOVA + Vector control set to 1. Data represent the mean ± SD of four biological replicates. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, ns: not significant; a one-way ANOVA followed by Tukey’s post hoc test. ENS-1/ERNI regulates the expression of genes affected by Soprano LTR CRISPRi (A) ENS-1/ERNI knockdown experiments. Cultured PGCs were transfected with DsiRNA, and gene expression was analyzed by RT-qPCR. Expression levels were normalized to GAPDH, with the control DsiRNA group set to 1. Data represent the mean ± SD of three biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; a one-way ANOVA followed by Dunnett’s post hoc test. (B) ENS-1/ERNI rescue experiments. CRISPRi PGCs were co-transfected with an ERNI expression plasmid and either 3× sgSoprano or 3× sgOVA expression plasmids. Gene expression was analyzed by RT-qPCR and normalized to GAPDH, with the 3× sgOVA + Vector control set to 1. Data represent the mean ± SD of four biological replicates. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001, ns: not significant; a one-way ANOVA followed by Tukey’s post hoc test. Regulation of the Soprano LTR in cultured PGCs CRISPRi experiments suggested that Soprano broadly regulates gene expression by functioning as a cis-regulatory element. Therefore, we investigated the regulatory mechanism of Soprano as a promoter and enhancer in PGCs. We randomly cloned several Soprano LTRs with varying sequences and examined their promoter activity using luciferase assays. As expected, some cloned Soprano LTRs exhibited high promoter activity, while others lacked promoter activity in cultured PGCs (Figure S7A; Table S14). A consensus motif analysis using the MEME suite43 on high-activity clones indicated conserved motifs in the proximal and distal regions of the Soprano LTR, whereas the central regions were not conserved (Figure S7B). Subsequent luciferase assays using proximal and distal region sequences showed that only the distal region sequence exhibited promoter activity in cultured PGCs (Figures 4A and S7C). These results are consistent with the findings of previous studies investigating Soprano LTR promoter activity in chicken embryonic stem cells.44,45 Furthermore, the Soprano LTR did not exhibit any promoter activity in the chicken fibroblast cell line DF-1, indicating the cell-type specificity of its promoter activity (Figure S7D). We then examined the conserved motifs in the distal region that were essential for promoter activity, and revealed that 35 bp of the motif 7 (motif 7 core) sequence was critical for activity (Figure 4A). Transcription factor-binding site predictions using JASPAR46 suggested that motif 7 contained the binding motifs for GATA/PRDM1, ELK/ETS, and homeobox/NANOG (Figure 4B; Table S15). Luciferase assays using point mutants of motif 7 showed that promoter activity was significantly reduced when the predicted homeobox/NANOG-binding site was mutated (Figure 4C). We also confirmed that the forced expression of NANOG in DF-1 cells increased Soprano LTR promoter activity (Figure 4D). Since NANOG is a central transcription factor regulating the pluripotency of stem cells in chickens47,48 and is highly expressed in PGCs, epiblasts, and ESCs,29,32,49 these results indicate that NANOG is also an important transcription factor for Soprano regulation in cultured PGCs. Although PRDM1 (also known as BLIMP1) is a key regulator of PGC specification50,51,52 and is also involved in chicken PGC development,32 the mutation of the predicted GATA/PRDM1-binding site did not affect promoter activity (Figure 4C). Furthermore, the forced expression of PRDM1 in DF-1 cells had no effect (Figure 4D), suggesting that PRDM1 did not enhance Soprano LTR activity. While a previous study suggested that GATA4 bound to these sites and its mutation reduced activity in chicken ESCs,44 the present results showed negligible effects in cultured PGCs (Figure 4C), possibly due to the low expression of GATA family genes in these cells (Figure S7E). We also investigated the enhancer activity of the Soprano LTR motif 7 core. Since enhancers function independently of their relative position,53 we evaluated the 3× motif 7 core sequence placed either upstream of a minimal TK promoter or downstream of the luciferase gene. Both configurations exhibited significant activity in cultured PGCs, although activity from the downstream position was weaker (Figure 4E). In DF-1 cells, the upstream construct showed increased activity upon the forced expression of NANOG, whereas the downstream construct remained inactive even with NANOG (Figure S7F). Therefore, while the Soprano LTR may possess enhancer activity, this activity is dependent on the cell type and requires additional stem cell-specific factors in addition to NANOG.Figure 4FGF signaling and NANOG regulate Soprano LTR expression in cultured PGCs(A–E) Dual luciferase assay evaluating Soprano LTR activities.(A) Promoter activity of serial Soprano LTR deletion mutants in cultured PGCs.(B) Sequence analysis of Soprano LTR motif 7. Substituted nucleotides in the mutants used in (C) are shown in red. Predicted transcription factor-binding sites based on the JASPAR analysis are highlighted in light blue.(C) Promoter activity of Soprano LTR motif 7 point mutants in cultured PGCs.(D) Effects of transcription factor overexpression on Soprano LTR in DF-1 cells.(E) Enhancer activity of the Soprano LTR motif 7 core sequence in cultured PGCs. In all assays, NanoLuc (NLuc) activity was normalized to firefly luciferase (FLuc).Data represent the mean ± SD of three biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, ns: not significant; a one-way ANOVA followed by Tukey’s post hoc test (A) or Dunnett’s post hoc test (C–E).(F) Inhibitor treatment experiment on cultured PGCs. PGCs were treated with PD0325901 or A83-01 for the indicated periods and gene expression was analyzed by RT-qPCR. The expression levels of ENS-1/ERNI and Soprano LTR were normalized to GAPDH, with values at 0 h set to 1. Statistical analyses were performed for each time point against the control (DMSO).Data represent the mean ± SD of four biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; a two-way ANOVA followed by Dunnett’s post hoc test. FGF signaling and NANOG regulate Soprano LTR expression in cultured PGCs (A–E) Dual luciferase assay evaluating Soprano LTR activities. (A) Promoter activity of serial Soprano LTR deletion mutants in cultured PGCs. (B) Sequence analysis of Soprano LTR motif 7. Substituted nucleotides in the mutants used in (C) are shown in red. Predicted transcription factor-binding sites based on the JASPAR analysis are highlighted in light blue. (C) Promoter activity of Soprano LTR motif 7 point mutants in cultured PGCs. (D) Effects of transcription factor overexpression on Soprano LTR in DF-1 cells. (E) Enhancer activity of the Soprano LTR motif 7 core sequence in cultured PGCs. In all assays, NanoLuc (NLuc) activity was normalized to firefly luciferase (FLuc). Data represent the mean ± SD of three biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, ns: not significant; a one-way ANOVA followed by Tukey’s post hoc test (A) or Dunnett’s post hoc test (C–E). (F) Inhibitor treatment experiment on cultured PGCs. PGCs were treated with PD0325901 or A83-01 for the indicated periods and gene expression was analyzed by RT-qPCR. The expression levels of ENS-1/ERNI and Soprano LTR were normalized to GAPDH, with values at 0 h set to 1. Statistical analyses were performed for each time point against the control (DMSO). Data represent the mean ± SD of four biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001; a two-way ANOVA followed by Dunnett’s post hoc test. The pluripotency and proliferation of cultured chicken PGCs are fundamentally controlled by FGF2/MAPK and Activin A/SMAD signaling.1 To identify the signaling pathway regulating the expression of the Soprano LTR, we performed inhibitor treatment experiments. PGCs were treated with PD0325901 (MEK inhibitor) or A83-01 (ALK4/5/7 inhibitor), and the expression levels of the Soprano LTR and ENS-1/ERNI were measured by qRT-PCR at specific time points (Figure 4F). In the vehicle (DMSO-) and A83-01-treated samples, a transient increase in Soprano LTR and ENS-1/ERNI expression was observed 1 h after medium replacement, possibly due to a stimulation by fresh growth factors. In A83-01-treated samples, the expression of these genes gradually decreased from 12 to 24 h. In contrast, in PD0325901-treated samples, expression levels remained unchanged at 1 h and then rapidly declined between 3 and 6 h. We also confirmed that the target pathways were functionally inhibited by assessing the phosphorylation of ERK1/2 and SMAD2 (Figures S7G and S7H). These results suggest that the expression of the Soprano LTR and ENS-1/ERNI is primarily regulated by FGF/MAPK signaling in cultured PGCs, which is consistent with a previous study showing that ectopic FGF8 administration induced ENS-1/ERNI expression in chick embryos.24 While Activin A/SMAD signaling also contributes to their expression, its role appears to be indirect. Collectively, these results suggest that the Soprano LTR exhibits potent promoter activity in chicken PGCs and also functions as an enhancer, with its expression is regulated by FGF signaling and NANOG binding to motif 7. Soprano LTR activity is involved in cell cycle progression during the induction of DNA damage in cultured PGCs Given the moderate correlation observed between ENS-1/ERNI expression levels and the number of days required for PGC establishment, we investigated whether Soprano LTR CRISPRi affected the cell cycle in cultured PGCs. Under normal conditions, Soprano LTR CRISPRi alone had no observable effect (Figure 5A). On the other hand, the induction of DNA damage with camptothecin (CPT), a topoisomerase I inhibitor that leads to DNA damage accumulation and subsequent apoptosis, affected the cell cycle distribution. The CPT treatment decreased the percentage of cells in the G0/G1 phase while increasing those in the G2/M phase, with higher CPT concentrations also affecting the S phase. Notably, Soprano LTR CRISPRi significantly increased the percentage of G2/M phase cells in a CPT dose-dependent manner (Figure 5A), suggesting that Soprano regulates cell cycle progression under DNA-damaged conditions. Consistent with these results, reduced cell proliferation was observed in these cells (Figure 5B). However, the percentage of apoptotic cells induced by the CPT treatment was not affected by Soprano LTR CRISPRi (Figure 5C). These results indicate that Soprano plays a modest role in the DNA damage response, specifically in cell cycle regulation, rather than directly modulating the apoptotic pathway.Figure 5Soprano LTR CRISPRi affects the cell cycle and proliferation of cultured PGCs under DNA damage conditions(A) Cell cycle analysis. Representative flow cytometry plots (top) and quantitative data (bottom) of cultured PGCs treated with the indicated concentrations of CPT under Soprano LTR CRISPRi conditions. Data represent the mean ± SD of three biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant; multiple t tests.(B) Cell proliferation assay. PGCs were treated with the indicated concentrations of CPT under Soprano LTR CRISPRi conditions. Data represent the mean ± SD of six biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, ns, not significant; the Student’s t test.(C) Apoptosis analysis. The percentage of apoptotic cells was measured using the JC-1 assay. Data represent the mean ± SD of three biological replicates. ns, not significant; the Student’s t test. Soprano LTR CRISPRi affects the cell cycle and proliferation of cultured PGCs under DNA damage conditions (A) Cell cycle analysis. Representative flow cytometry plots (top) and quantitative data (bottom) of cultured PGCs treated with the indicated concentrations of CPT under Soprano LTR CRISPRi conditions. Data represent the mean ± SD of three biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant; multiple t tests. (B) Cell proliferation assay. PGCs were treated with the indicated concentrations of CPT under Soprano LTR CRISPRi conditions. Data represent the mean ± SD of six biological replicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, ns, not significant; the Student’s t test. (C) Apoptosis analysis. The percentage of apoptotic cells was measured using the JC-1 assay. Data represent the mean ± SD of three biological replicates. ns, not significant; the Student’s t test. Soprano LTR activity is critical for early chicken PGC development in ovo Finally, to elucidate the role of Soprano in PGC development in ovo, we performed transplantation experiments using Soprano LTR CRISPRi PGCs (Figure 6A). Equal numbers of EGFP-labeled Soprano LTR CRISPRi PGCs and mCherry-labeled control PGCs were co-transplanted into EG&K St. X54 blastoderms or into HH St.14–1655 embryo blood. After a further incubation for 3.5 days, the genital ridges or gonads were harvested and stained with an anti-SSEA-1 antibody as a PGC marker. The percentages of EGFP- and mCherry-labeled cells among SSEA-1-positive PGCs were analyzed by flow cytometry, and the ratio of Soprano LTR CRISPRi (EGFP+) PGCs relative to the total transplanted (EGFP+ and mCherry+) population was calculated (Figures 6B and 6C). When transplanted into blastoderms, the percentage of Soprano LTR CRISPRi PGCs colonizing the E3.5 genital ridges was significantly lower than that of control cells. In contrast, Soprano LTR CRISPRi did not affect the colonization of E6 gonads when cells were transplanted into HH St. 14–16 embryos. These results suggest that Soprano is important for the development of early-stage PGCs, whereas it is dispensable for their colonization of the genital ridges from the circulation.Figure 6Soprano LTR CRISPRi inhibits PGC development in ovo(A) Experimental scheme for the transplantation of Soprano LTR CRISPRi PGCs.(B and C) Colonization efficiency of Soprano LTR CRISPRi PGCs in the embryonic gonadal region. CRISPRi PGCs were transplanted into (B) EG&K St. X blastoderms or (C) HH St. 14–16 blood vessels. After a 3.5-day incubation, genital ridges (B) or gonads (C) were harvested and stained for SSEA-1. SSEA-1-positive (total PGCs) and EGFP- or mCherry-positive (transplanted PGCs) cells were analyzed by flow cytometry. The ratio of Soprano LTR CRISPRi (EGFP+) cells among the total transplanted PGC population was calculated.Data represent values for individual embryos; (B) n = 23, (C) n = 37; with horizontal lines indicating the median. The red dashed line represents the expected ratio (0.5). ∗∗∗∗p < 0.0001, ns, not significant; the one-sample Wilcoxon signed-rank test. Soprano LTR CRISPRi inhibits PGC development in ovo (A) Experimental scheme for the transplantation of Soprano LTR CRISPRi PGCs. (B and C) Colonization efficiency of Soprano LTR CRISPRi PGCs in the embryonic gonadal region. CRISPRi PGCs were transplanted into (B) EG&K St. X blastoderms or (C) HH St. 14–16 blood vessels. After a 3.5-day incubation, genital ridges (B) or gonads (C) were harvested and stained for SSEA-1. SSEA-1-positive (total PGCs) and EGFP- or mCherry-positive (transplanted PGCs) cells were analyzed by flow cytometry. The ratio of Soprano LTR CRISPRi (EGFP+) cells among the total transplanted PGC population was calculated. Data represent values for individual embryos; (B) n = 23, (C) n = 37; with horizontal lines indicating the median. The red dashed line represents the expected ratio (0.5). ∗∗∗∗p < 0.0001, ns, not significant; the one-sample Wilcoxon signed-rank test. Discussion In the present study, we performed transcriptome analyses of cultured PGCs derived from closed or inbred strains of chickens to elucidate the molecular factors underlying differences in EE among sexes and strains. Our results demonstrated that differences in gene expression profiles across PGC lines were primarily dependent on strain, while sex had a minimal impact on overall transcriptional variations. Among the DEGs identified across strains, we selected ENS-1/ERNI and its LTR, Soprano, for further investigation. A functional analysis using CRISPRi revealed that they exerted moderate, yet broad control over PGC homeostasis gene networks, including those related to ribosome, the endoplasmic reticulum, and oxidative phosphorylation (Figures 2A, 2B, and S4D). Furthermore, while Soprano LTR CRISPRi did not affect the cell cycle of healthy PGCs, it significantly increased the percentage of cells arrested in the G2/M phase and reduced cell proliferation following the CPT treatment (Figures 5A and 5B). CPT is known to induce replication-mediated DNA damage, which activates intra-S phase checkpoints, leading to S-phase arrest and delayed progression to the G2/M phase.56,57 Our findings suggest that Soprano LTR CRISPRi may impair these DNA damage response mechanisms, potentially leading to premature mitotic entry and the subsequent accumulation of cells in the G2/M phase. Interestingly, Soprano LTR CRISPRi significantly down-regulated the expression of WEE2 in cultured PGCs (Figures 2A and 2C). WEE2 belongs to the Wee kinase family (WEE1, WEE2, and PKMYT1), which regulates the G2/M checkpoint by inhibiting CDK1 activity.58,59,60,61 While WEE1 is ubiquitously expressed and mediates the intra-S phase checkpoint via CDK2, the role of germline-specific WEE2 remains unclear, with most studies focusing on its function in oocyte meiotic arrest and subsequent maturation.59,60,61,62,63,64 Although the specific function of WEE2 in PGCs has not been reported, our data showed the high expression of both WEE1 and WEE2 in chicken PGCs (Figure S8). Furthermore, recent studies reported that chicken PGCs possessed more robust DNA repair systems and the lower expression of apoptosis-related genes than somatic cells.65 Consistent with these findings, our results imply that Soprano activity partially regulates cell cycle progression via WEE2, which may be important for ensuring sufficient time to repair DNA damage before mitotic entry, thereby maintaining genomic integrity in chicken PGCs. In summary, our transcriptome analysis under CRISPRi conditions, combined with cell cycle and proliferation assays under DNA-damaged conditions, suggests that the Soprano LTR and/or ENS-1/ERNI possibly contribute to the successful establishment of PGC lines by maintaining cellular homeostasis and regulating proliferation. However, due to technical limitations, this study was unable to directly demonstrate whether the overexpression of the Soprano LTR or ENS-1/ERNI in in ovo PGCs enhanced EE. Therefore, to establish whether the correlation between ENS-1/ERNI expression and EE is causative or consequential, further investigations are required. This may involve identifying small molecules or reagents that up-regulate the expression of the Soprano LTR and ENS-1/ERNI to confirm their impact on PGC establishment. Following Soprano LTR CRISPRi, significant decreases in the expression levels of several protein-coding genes were observed (Figure 2C). Notably, some of these genes possessed solo Soprano LTRs in their flanking regions (Figure S4F). Luciferase assays and inhibitor treatment experiments demonstrated that the Soprano LTR was activated by FGF2/MAPK signaling and transcriptionally regulated by the pluripotency factor NANOG (Figures 4 and S7). Furthermore, the Soprano LTR exhibited enhancer activity in cultured PGCs, suggesting that it functions not only as a promoter for ENS-1/ERNI, but also as a distal enhancer for other genes. Additionally, our recent ATAC-seq analysis comparing cultured chicken PGCs and somatic cells revealed that Soprano LTR regions, together with ENS-1/ERNI loci, exhibited preferential chromatin accessibility in PGCs. This independent epigenomic evidence supports the notion that Soprano functions as an active cis-regulatory element in the germ cell context.66 In addition to this cis-regulatory role, knockdown and rescue experiments demonstrated that the ENS-1/ERNI protein independently up-regulated the expression of most of these target genes (Figures 3A and 3B). ENS-1/ERNI proteins are known to localize to both the cytoplasm and nucleus in undifferentiated cells. In neural plate cells, they act as transcriptional repressors via an N-terminal coiled-coil domain (SMC superfamily) and C-terminal CBX3-binding domain.25,26 Therefore, while the present results indicate that ENS-1/ERNI appears to function as a transcriptional regulator in cultured PGCs, further investigations are required to clarify whether it regulates these genes directly or through other transcriptional and/or epigenetic modulators. Moreover, future studies need to examine the possibility of feedback by ENS-1/ERNI proteins to regulate the activity of the Soprano LTR itself, as well as other solo Soprano elements across the genome. The transplantation of Soprano LTR CRISPRi PGCs into the bloodstream of HH St. 14–16 embryos did not impair their subsequent colonization of the genital ridges. In contrast, their colonization was significantly reduced when these cells were transplanted into blastoderms (Figures 6B and 6C). These results suggest that Soprano and/or ENS-1/ERNI play important roles during the early stages of PGC development, prior to the blood circulation stage. In chicken embryos, PGCs originate in the central region of the area pellucida at EG&K St. X and migrate through the prospective neural plate to the germinal crescent, located in the anterior part of the embryo by HH St. 4.67 They then enter the vasculature around HH St. 8 to circulate throughout the embryo.68 Consistent with previous studies demonstrating that ENS-1/ERNI controls the timing of neurogenesis,25,26 our Soprano LTR CRISPRi experiments revealed the up-regulation of neurogenesis-related genes in cultured PGCs. This suggests that Soprano and ENS-1/ERNI potentially function to suppress misdirected neurogenic signaling within in ovo PGCs during gastrulation, thereby maintaining their germline identity. Beyond these early developmental roles, our results also revealed that Soprano and ENS-1/ERNI regulated oocyte-specific kinase WEE2. Therefore, whether these elements contribute to germ cell development at later stages, such as gametogenesis, remains an intriguing question to be addressed. However, since the present results are based on the CRISPRi-mediated inhibition of Soprano LTR activity, they reflect the combined effects of Soprano as a cis-regulatory element and the loss of the ENS-1/ERNI protein. Future studies are needed to decouple these factors and elucidate their individual contributions and detailed MFs in both in ovo germ cell development and in vitro PGC homeostasis. As the fundamental precursors for gametogenesis, PGCs possess multi-layered defense mechanisms to silence TEs and maintain genomic stability69 In chicken PGCs, the piRNA pathway suppresses TEs, and its down-regulation leads to increased DNA double-strand breakage through TE reactivation.70 Conversely, certain TEs escape these silencing mechanisms and are co-opted by the host for essential biological functions. For example, LTR retrotransposons act as enhancers and are involved in human PGC specification.20 Our results align with growing evidence that TEs, when integrated into the host gene expression circuitry and precisely regulated, play significant roles in both somatic and germline development.15,18,19 Notably, while birds have undergone genome size reductions and possess a lower percentage of TEs than other amniotes,22 our results highlight that even a small number of conserved TEs may play important roles in germline development, similar to the mechanisms observed in mammals. Since Soprano and ENS-1/ERNI are Galliformes-specific, different TEs or genes may perform analogous roles in other avian species, reflecting the evolutionary diversity and convergent strategy of germline development. Furthermore, we showed that sequence variations in the Soprano LTR affected its regulatory activity (Figure S7A). This suggests that even within the same chicken species, polymorphisms or differences in genomic insertion sites among breeds affect PGC properties and possibly their EE. Collectively, these insights will advance our understanding of avian PGC development and provide a theoretical foundation for optimizing in vitro culture methods across diverse genetic resources. Limitations of the study Although this study demonstrates a significant correlation between ENS-1/ERNI expression levels and the EE of cultured PGCs, whether this correlation is causative or consequential remains to be elucidated. Due to technical constraints, we were unable to directly test whether the forced expression of ERNI can rescue or enhance EE in chicken strains with low EE. Therefore, further functional validation, specifically evaluating whether the ectopic expression of ERNI or the application of small molecules that up-regulate the Soprano LTR can improve EE in low-efficiency strains, is required to establish definitive causality. Our functional insights are primarily based on the CRISPRi-mediated inhibition of Soprano LTR activity. Because this approach simultaneously represses multiple repetitive genomic loci, our findings reflect the combined effects of the Soprano LTRs as a cis-regulatory element and the loss of the ENS-1/ERNI protein. Future studies are required to decouple these two factors to fully elucidate their individual contributions and distinct MFs in both in ovo germ cell development and in vitro PGC homeostasis. Resource availability Lead contact Requests for further information and resources should be directed to and will be fulfilled by the lead contact, Yuya Okuzaki (yo0619@nuagr1.agr.nagoya-u.ac.jp). Materials availability All unique/stable reagents generated in this study are available from the lead contact with a completed material transfer agreement. Data and code availability Raw sequencing data from the present study are publicly available in the DDBJ BioProject (PRJDB35733) (https://ddbj.nig.ac.jp/search/entry/bioproject/PRJDB35733). Acknowledgments This work was supported by a “Strategic Research Projects” grant from the 10.13039/100013328ROIS (10.13039/100013328Research Organization of Information and Systems) (A.K), Grants-in-Aid for Scientific Research 10.13039/501100001691KAKENHI (C) 22K15027 (Y. Okuzaki), and (C) 23K05798 (K.i.N.), and the 10.13039/501100001700MEXT (Ministry of Education, Culture, Sports, Science and Technology) National BioResource Project JPNBRP202205 (K.i.N.). The piggyBac plasmid and piggyBac transposase expression plasmid were kindly gifted by Dr. Akitsu Hotta.71 Author contributions Conceptualization, Y. Okuzaki and K.i.N.; data curation, Y. Okuzaki, A.K., Y. Ozaki, and K.i.N.; formal analysis, Y. Okuzaki and A.K.; funding acquisition, Y. Okuzaki, A.K., and K.i.N.; investigation, Y. Okuzaki, A.K., Y. Ozaki, and T.U.; methodology, Y. Okuzaki and A.K.; project administration, Y. Okuzaki, S.D., and K.i.N.; resources, Y. Okuzaki, A.K., T.U., and K.i.N.; supervision, S.D and K.i.N.; validation, Y. Okuzaki; visualization, Y. Okuzaki and A.K.; writing – original draft, Y. Okuzaki and K.i.N.; writing – review and editing, Y. Okuzaki, A.K., D.S., and K.i.N. Declaration of interests The authors declare no competing interests. Declaration of generative AI and AI-assisted technologies in the writing process During the preparation of this work the authors used Google Gemini in order to check grammar. After using this service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. STAR★Methods Key resources table REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesENS-1 antibody (16h4)CovalabCat#Mab0137-P; RRID: AB_3751492Anti-Cadherin 7 antibodyAbcamCat#ab237754; RRID: AB_3751491Phospho-SMAD2 (Ser465/467) (138D4) Rabbit Monoclonal AntibodyCell Signaling TechnologyCat#3108; RRID: AB_490941Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) AntibodyCell Signaling TechnologyCat#9101; RRID:AB_331646Anti-β-ActinMBL InternationalCat#M177-3; RRID:AB_10697039Anti-IgG (H+L chain) (Rabbit) pAb-HRPMBL InternationalCat#458; RRID:AB_2827722Anti-IgG (H+L chain) (Mouse) pAb-HRPMBL InternationalCat#330; RRID:AB_2650507BD Horizon BV421 Mouse Anti-SSEA-1BD BiosciencesCat#562705; RRID:AB_2737733Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488Thermo Fisher ScientificCat#A-21206; RRID:AB_2535792Goat anti-Mouse IgG2b Cross-Adsorbed Secondary Antibody, Alexa Fluor 647Thermo Fisher ScientificCat# A-21242; RRID:AB_2535811Bacterial and virus strainsEscherichia coli, strain: DH5aTakaraCat#9057Chemicals, peptides, and recombinant proteinsAvian KnockOut DMEMThermo Fisher ScientificCustom madeD-MEM (High Glucose)FujifilmCat#048-29763MEM Non-Essential Amino Acids SolutionThermo Fisher ScientificCat#11400500GlutaMAX SupplementThermo Fisher ScientificCat#35050061Sodium PyruvateThermo Fisher ScientificCat#11360070B-27 Supplement (50X), minus vitamin AThermo Fisher ScientificCat#12587001Penicillin -StreptomycinThermo Fisher ScientificCat#15140122Chicken SerumThermo Fisher ScientificCat#16110082Fetal Bovine SerumMerckCat#173012; Rot#BCBZ5443Monothioglycerol SolutionFujifilmCat#195-15791CELLBANKER 2Takara BioCat#11914TrypLE Express EnzymeThermo Fisher ScientificCat#12605028Trypsin-EDTA (0.25%)Thermo Fisher ScientificCat#25200072EmbryoMax NucleosidesMerckCat#ES-008OvotransferrinMerckCat#C7786; CAS# 1391-06-6OvalbuminMerckCat#A5503; CAS# 9006-59-1Sodium heparinMerckCat#SRE0027; CAS# 9041-08-1Proteinase KFujifilmCat#161-28701; CAS# 39450-01-6CamptothecinFujifilmCat#038-18191; CAS# 7689-03-4Puromycin DihydrochlorideFujifilmCat#166-23153; CAS# 58-58-2Blasticidin S HydrochlorideFujifilmCat#029-18701; CAS# 3513-03-9A-83-01FujifilmCat#039-24111; CAS# 909910-43-6PD0325901FujifilmCat#518-91701; CAS# 391210-10-9Dimethyl SulfoxideFujifilmCat#046-21981; CAS# 67-68-5Sodium ChlorideFujifilmCat#191-01665; CAS# 7647-14-5Potassium ChlorideFujifilmCat#163-0354; CAS# 7447-40-7Magnesium ChlorideFujifilmCat#136-03995; CAS# 7786-30-3Sodium Dodecyl SulfateFujifilmCat#190-13985; CAS# 151-21-32-MercaptoethanolFujifilmCat#137-07521; CAS# 60-24-2Tween 20FujifilmCat#167-11515; CAS# 9005-64-5MethanolFujifilmCat#137-01823; CAS# 67-56-1Triton X-100FujifilmCat#A16046; CAS# 9002-93-1Bromophenol blueFujifilmCat#021-02911; CAS# 115-39-9Tris(hydroxymethyl)aminomethaneNacalaiCat#35406-91; CAS# 77-86-1NP-40NacalaiCat#25223-04; CAS# 9016-45-9AgaroseNacalaiCat# 02468-95; CAS# 9012-36-6Activin A, Human/Mouse/Rat, RecombinantPeprotechCat#120-14Recombinant Human FGF2R&D systemsCat#233-FBNEBuilder® HiFi DNA Assembly Master MixNew England BiolabsCat#E2621KOD Fx NeoToyoboCat#KFX-201KOD OneToyoboCat#KMM-201ReverTra Ace qPCR RT Master MixToyoboCat#FSQ-201THUNDERBIRD® Next SYBR™ qPCR MixToyoboCat#QPX-201Can Get Signal Solution 1 & 2ToyoboCat#NKB-101PVDF Blocking Reagent for Can Get Signal®ToyoboCat#NYPBR01Western BLoT Hyper HRP SubstrateTakaraCat#T7103ALipofectamine™ 2000 Transfection ReagentThermo Fisher ScientificCat#11668019Lipofectamine™ 3000 Transfection ReagentThermo Fisher ScientificCat#L3000015Lipofectamine RNAiMAX Transfection ReagentThermo Fisher ScientificCat#13778150FastGene™ BLUE Star Prestained Protein-LadderNippon GeneticsCat#NE-MWP03FastGene™ 100bp DNA Ladder PLUSNippon GeneticsCat#NE-MWD100PFastGene™ 1 kb DNA Ladder PLUSNippon GeneticsCat#NE-MWD1PCritical commercial assaysViahance Dead Cell Removal KitBiopalCat# CP-50VQ02Cell Counting Kit-8DojindoCat# 343-07623Cell Cycle Assay Solution BlueDojindoCat# 341-09601Easy DNA extraction kit version 2KanekaCat#KN-B101005MitoPT JC-1 Assay kitImmunoChemistry TechnologiesCat#924ReliaPrep RNA Miniprep SystemsPromegaCat#Z6010Nano-Glo Dual-Luciferase reporter assay systemPromegaCat#N1620DNeasy Blood & Tissue KitQiagenCat#69506Deposited dataRNAseq datasets (cultured PGCs, CRISPRi PGCs)This paperDDBJ: BioProject PRJDB35733RNAseq datasets (in vivo PGCs)Ichikawa et al.36Experimental models: Cell linesChicken: embryonic fibroblasts (Strain: M/O)This paperN/AChicken: primordial germ cells, (Strains: GSP, GSN/1, PNP, WLG, M/O, BLE, GB, OS, DD, BMC, POL, BRB, PC, JB, EJ, SIL, CHN, CB, KS, CAL, TK, GRN)This paperN/AChicken: DF1ATCCCat#CRL-3586Experimental models: Organisms/strainsChicken: Strains: GSP, GSN/1, PNP, WLG, M/O, BLE, GB, OS, DD, BMC, POL, BRB, PC, JB, EJ, SIL, CHN, CB, KS, CAL, TK, GRNAvian Bioscience Research Center, Nagoya Universityhttps://www.agr.nagoya-u.ac.jp/∼nbrp/en/resources/index.htmlChicken: Strain: NGYAichi Agricultural Research CenterN/AChicken: host eggs for transplantation experimentsTakeuchi HatcheryN/AOligonucleotidesSee Table S16 for primersThis paperN/ASee Table S16 for DsiRNAsThis paper, IDTCustom order and Control CAT#51-01-14-04See Table S16 for gRNA spacer sequencesThis paperN/ARecombinant DNAdCas9-KRAB-MeCP2Yeo et al.42 AddgeneCat#110821pU6-(BbsI)_CBh-Cas9-T2A-mCherryChu et al.72 AddgeneCat#64324pX330_CBH:spCas9-T2A-PuroR-pA_mU6:sgRNA (ENS-1/ERNI #1)This paperN/ApX330_CBH:spCas9-T2A-PuroR-pA_mU6:sgRNA (ENS-1/ERNI #2)This paperN/ApX330_CBH:spCas9-T2A-PuroR-pA_mU6:sgRNA (ENS-1/ERNI #3)This paperN/ApPV_CAG:dCas9-KRAB-MeCP2-pA_EF1α:BsdR-pAThis paperN/ApcDNA4_CMV::EGFP-pAThis paperN/ApcDNA4_CMV::ERNI-pAThis paperN/ApcDNA4_CMV::EGFP-NANOG-pAThis paperN/ApcDNA4_CMV::EGFP-PRDM1-pAThis paperN/ApNL1.1[Nluc]PromegaCat#N1501pNL1.1_Soprano:Nluc-pAThis paperN/ApGL4.54[luc2/TK]PromegaCat#E5061pPV_EF1a:EGFP-IRES-PuroR-pAAkitsu Hotta71N/ApPV_3×(mU6:sgSoprano)_EF1α:EGFP-IRES-PuroR-pAThis paperN/ApPV_3×(mU6:sgOVA)_EF1α:mCherry-IRES-PuroR-pAThis paperN/ApPV_3×(mU6:sgSoprano)_EF1α:BFP-WPRE-pAThis paperN/ApPV_3×(mU6:sgOVA)_EF1α:BFP-WPRE-pAThis paperN/ApHLS_EF1a:hcPBase-pAAkitsu Hotta71N/AcDNA: chicken NANOGThis paperNCBI Reference Sequence: NM_001146142.2cDNA: chicken PRDM1This paperNCBI Reference Sequence: XM_040666817.2cDNA: chicken ERNI (also see Table Sxxx)This paperNCBI Reference Sequence: NM_001080874.1Software and algorithmsFlowjoBD Bioscienceshttps://www.flowjo.com/GrapghPad PrismGrapghPadhttps://www.graphpad.com/SnapGene ViewerSnapGenehttps://www.snapgene.com/R (version 4.4.2)N/Ahttps://www.r-project.org/fastpChen et al.73https://github.com/OpenGene/fastpHISAT2Kim et al.74http://daehwankimlab.github.io/hisat2/SamtoolsDanecek et al.75https://github.com/samtools/samtoolsSubreadLiao et al.76https://github.com/ShiLab-Bioinformatics/subreadedgeRRobinson et al.77https://bioconductor.org/packages/release/bioc/html/edgeR.htmlTPMCalculatorAlvarez et al.78https://github.com/NLM-DIR/TPMCalculatorg:ProfilerKolberg et al.79https://biit.cs.ut.ee/gprofiler/gostClusterProfilerYu et al.80https://bioconductor.org/packages/release/bioc/html/clusterProfiler.htmlMEME SuiteBailey et al.43https://meme-suite.org/meme/JASPARSandelin et al.46https://jaspar.elixir.no/CRISPR-ICEConant et al.81https://ice.editco.bio/InterveneKhan et al.82https://asntech.shinyapps.io/intervene/CS Analyzer 4Attohttps://www.atto.co.jp/products/imaging_analysis/OtherCell sorter (SH800S)Sonyhttps://www.sony.co.jp/Products/LifeScience/fcm/products/sh800s/Cell sorter (BD FACSJazz)BD Bioscienceshttps://www.bdbiosciences.com/LightCycler 96 SystemRochehttps://diagnostics.roche.com/T100 Thermal cyclerBio-Radhttps://www.bio-rad.com/Trans-blot SD semi-dry transfer cellBio-Radhttps://www.bio-rad.com/Lumino Graph Ⅰ CMOSAttohttps://www.atto.co.jp/products/imaging_analysis/Plate reader (TECAN Infinite200PRO)Tecanhttps://www.tecan.com/Plate reader (MULTISKAN FC)Thermo Fisher ScientificCat#51119000SZ61 Stereo MicroscopeEvidenthttps://evidentscientific.com/CKX53 Cell Culture MicroscopeEvidenthttps://evidentscientific.com/CO2 incubatorPhcbihttps://www.phchd.com/Qubit 4 FluorometerThermo Fisher ScientificCat#Q33238Countess 3 FL Automated Cell CounterThermo Fisher ScientificCat#AMQAF2000Amersham Hybond P PVDF 0.2CytivaCat#10600021PC-100 PullerNarishigehttps://products.narishige-group.com/MF3 MicroforgeNarishigehttps://products.narishige-group.com/EG-45 MicrogrinderNarishigehttps://products.narishige-group.com/GD-1 grass capillary with filamentNarishigehttps://products.narishige-group.com/P-008 Egg incubatorShowa Furankihttp://www.showafuranki.com/PTFE membraneKokugohttps://enet.kokugo.shop/Plastic wrapAsahi Kaseihttps://www.asahi-kasei.co.jp/saran/scotch tape3Mhttps://www.scotchbrand.com/3M/ REAGENT or RESOURCESOURCEIDENTIFIERAntibodiesENS-1 antibody (16h4)CovalabCat#Mab0137-P; RRID: AB_3751492Anti-Cadherin 7 antibodyAbcamCat#ab237754; RRID: AB_3751491Phospho-SMAD2 (Ser465/467) (138D4) Rabbit Monoclonal AntibodyCell Signaling TechnologyCat#3108; RRID: AB_490941Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) AntibodyCell Signaling TechnologyCat#9101; RRID:AB_331646Anti-β-ActinMBL InternationalCat#M177-3; RRID:AB_10697039Anti-IgG (H+L chain) (Rabbit) pAb-HRPMBL InternationalCat#458; RRID:AB_2827722Anti-IgG (H+L chain) (Mouse) pAb-HRPMBL InternationalCat#330; RRID:AB_2650507BD Horizon BV421 Mouse Anti-SSEA-1BD BiosciencesCat#562705; RRID:AB_2737733Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488Thermo Fisher ScientificCat#A-21206; RRID:AB_2535792Goat anti-Mouse IgG2b Cross-Adsorbed Secondary Antibody, Alexa Fluor 647Thermo Fisher ScientificCat# A-21242; RRID:AB_2535811Bacterial and virus strainsEscherichia coli, strain: DH5aTakaraCat#9057Chemicals, peptides, and recombinant proteinsAvian KnockOut DMEMThermo Fisher ScientificCustom madeD-MEM (High Glucose)FujifilmCat#048-29763MEM Non-Essential Amino Acids SolutionThermo Fisher ScientificCat#11400500GlutaMAX SupplementThermo Fisher ScientificCat#35050061Sodium PyruvateThermo Fisher ScientificCat#11360070B-27 Supplement (50X), minus vitamin AThermo Fisher ScientificCat#12587001Penicillin -StreptomycinThermo Fisher ScientificCat#15140122Chicken SerumThermo Fisher ScientificCat#16110082Fetal Bovine SerumMerckCat#173012; Rot#BCBZ5443Monothioglycerol SolutionFujifilmCat#195-15791CELLBANKER 2Takara BioCat#11914TrypLE Express EnzymeThermo Fisher ScientificCat#12605028Trypsin-EDTA (0.25%)Thermo Fisher ScientificCat#25200072EmbryoMax NucleosidesMerckCat#ES-008OvotransferrinMerckCat#C7786; CAS# 1391-06-6OvalbuminMerckCat#A5503; CAS# 9006-59-1Sodium heparinMerckCat#SRE0027; CAS# 9041-08-1Proteinase KFujifilmCat#161-28701; CAS# 39450-01-6CamptothecinFujifilmCat#038-18191; CAS# 7689-03-4Puromycin DihydrochlorideFujifilmCat#166-23153; CAS# 58-58-2Blasticidin S HydrochlorideFujifilmCat#029-18701; CAS# 3513-03-9A-83-01FujifilmCat#039-24111; CAS# 909910-43-6PD0325901FujifilmCat#518-91701; CAS# 391210-10-9Dimethyl SulfoxideFujifilmCat#046-21981; CAS# 67-68-5Sodium ChlorideFujifilmCat#191-01665; CAS# 7647-14-5Potassium ChlorideFujifilmCat#163-0354; CAS# 7447-40-7Magnesium ChlorideFujifilmCat#136-03995; CAS# 7786-30-3Sodium Dodecyl SulfateFujifilmCat#190-13985; CAS# 151-21-32-MercaptoethanolFujifilmCat#137-07521; CAS# 60-24-2Tween 20FujifilmCat#167-11515; CAS# 9005-64-5MethanolFujifilmCat#137-01823; CAS# 67-56-1Triton X-100FujifilmCat#A16046; CAS# 9002-93-1Bromophenol blueFujifilmCat#021-02911; CAS# 115-39-9Tris(hydroxymethyl)aminomethaneNacalaiCat#35406-91; CAS# 77-86-1NP-40NacalaiCat#25223-04; CAS# 9016-45-9AgaroseNacalaiCat# 02468-95; CAS# 9012-36-6Activin A, Human/Mouse/Rat, RecombinantPeprotechCat#120-14Recombinant Human FGF2R&D systemsCat#233-FBNEBuilder® HiFi DNA Assembly Master MixNew England BiolabsCat#E2621KOD Fx NeoToyoboCat#KFX-201KOD OneToyoboCat#KMM-201ReverTra Ace qPCR RT Master MixToyoboCat#FSQ-201THUNDERBIRD® Next SYBR™ qPCR MixToyoboCat#QPX-201Can Get Signal Solution 1 & 2ToyoboCat#NKB-101PVDF Blocking Reagent for Can Get Signal®ToyoboCat#NYPBR01Western BLoT Hyper HRP SubstrateTakaraCat#T7103ALipofectamine™ 2000 Transfection ReagentThermo Fisher ScientificCat#11668019Lipofectamine™ 3000 Transfection ReagentThermo Fisher ScientificCat#L3000015Lipofectamine RNAiMAX Transfection ReagentThermo Fisher ScientificCat#13778150FastGene™ BLUE Star Prestained Protein-LadderNippon GeneticsCat#NE-MWP03FastGene™ 100bp DNA Ladder PLUSNippon GeneticsCat#NE-MWD100PFastGene™ 1 kb DNA Ladder PLUSNippon GeneticsCat#NE-MWD1PCritical commercial assaysViahance Dead Cell Removal KitBiopalCat# CP-50VQ02Cell Counting Kit-8DojindoCat# 343-07623Cell Cycle Assay Solution BlueDojindoCat# 341-09601Easy DNA extraction kit version 2KanekaCat#KN-B101005MitoPT JC-1 Assay kitImmunoChemistry TechnologiesCat#924ReliaPrep RNA Miniprep SystemsPromegaCat#Z6010Nano-Glo Dual-Luciferase reporter assay systemPromegaCat#N1620DNeasy Blood & Tissue KitQiagenCat#69506Deposited dataRNAseq datasets (cultured PGCs, CRISPRi PGCs)This paperDDBJ: BioProject PRJDB35733RNAseq datasets (in vivo PGCs)Ichikawa et al.36Experimental models: Cell linesChicken: embryonic fibroblasts (Strain: M/O)This paperN/AChicken: primordial germ cells, (Strains: GSP, GSN/1, PNP, WLG, M/O, BLE, GB, OS, DD, BMC, POL, BRB, PC, JB, EJ, SIL, CHN, CB, KS, CAL, TK, GRN)This paperN/AChicken: DF1ATCCCat#CRL-3586Experimental models: Organisms/strainsChicken: Strains: GSP, GSN/1, PNP, WLG, M/O, BLE, GB, OS, DD, BMC, POL, BRB, PC, JB, EJ, SIL, CHN, CB, KS, CAL, TK, GRNAvian Bioscience Research Center, Nagoya Universityhttps://www.agr.nagoya-u.ac.jp/∼nbrp/en/resources/index.htmlChicken: Strain: NGYAichi Agricultural Research CenterN/AChicken: host eggs for transplantation experimentsTakeuchi HatcheryN/AOligonucleotidesSee Table S16 for primersThis paperN/ASee Table S16 for DsiRNAsThis paper, IDTCustom order and Control CAT#51-01-14-04See Table S16 for gRNA spacer sequencesThis paperN/ARecombinant DNAdCas9-KRAB-MeCP2Yeo et al.42 AddgeneCat#110821pU6-(BbsI)_CBh-Cas9-T2A-mCherryChu et al.72 AddgeneCat#64324pX330_CBH:spCas9-T2A-PuroR-pA_mU6:sgRNA (ENS-1/ERNI #1)This paperN/ApX330_CBH:spCas9-T2A-PuroR-pA_mU6:sgRNA (ENS-1/ERNI #2)This paperN/ApX330_CBH:spCas9-T2A-PuroR-pA_mU6:sgRNA (ENS-1/ERNI #3)This paperN/ApPV_CAG:dCas9-KRAB-MeCP2-pA_EF1α:BsdR-pAThis paperN/ApcDNA4_CMV::EGFP-pAThis paperN/ApcDNA4_CMV::ERNI-pAThis paperN/ApcDNA4_CMV::EGFP-NANOG-pAThis paperN/ApcDNA4_CMV::EGFP-PRDM1-pAThis paperN/ApNL1.1[Nluc]PromegaCat#N1501pNL1.1_Soprano:Nluc-pAThis paperN/ApGL4.54[luc2/TK]PromegaCat#E5061pPV_EF1a:EGFP-IRES-PuroR-pAAkitsu Hotta71N/ApPV_3×(mU6:sgSoprano)_EF1α:EGFP-IRES-PuroR-pAThis paperN/ApPV_3×(mU6:sgOVA)_EF1α:mCherry-IRES-PuroR-pAThis paperN/ApPV_3×(mU6:sgSoprano)_EF1α:BFP-WPRE-pAThis paperN/ApPV_3×(mU6:sgOVA)_EF1α:BFP-WPRE-pAThis paperN/ApHLS_EF1a:hcPBase-pAAkitsu Hotta71N/AcDNA: chicken NANOGThis paperNCBI Reference Sequence: NM_001146142.2cDNA: chicken PRDM1This paperNCBI Reference Sequence: XM_040666817.2cDNA: chicken ERNI (also see Table Sxxx)This paperNCBI Reference Sequence: NM_001080874.1Software and algorithmsFlowjoBD Bioscienceshttps://www.flowjo.com/GrapghPad PrismGrapghPadhttps://www.graphpad.com/SnapGene ViewerSnapGenehttps://www.snapgene.com/R (version 4.4.2)N/Ahttps://www.r-project.org/fastpChen et al.73https://github.com/OpenGene/fastpHISAT2Kim et al.74http://daehwankimlab.github.io/hisat2/SamtoolsDanecek et al.75https://github.com/samtools/samtoolsSubreadLiao et al.76https://github.com/ShiLab-Bioinformatics/subreadedgeRRobinson et al.77https://bioconductor.org/packages/release/bioc/html/edgeR.htmlTPMCalculatorAlvarez et al.78https://github.com/NLM-DIR/TPMCalculatorg:ProfilerKolberg et al.79https://biit.cs.ut.ee/gprofiler/gostClusterProfilerYu et al.80https://bioconductor.org/packages/release/bioc/html/clusterProfiler.htmlMEME SuiteBailey et al.43https://meme-suite.org/meme/JASPARSandelin et al.46https://jaspar.elixir.no/CRISPR-ICEConant et al.81https://ice.editco.bio/InterveneKhan et al.82https://asntech.shinyapps.io/intervene/CS Analyzer 4Attohttps://www.atto.co.jp/products/imaging_analysis/OtherCell sorter (SH800S)Sonyhttps://www.sony.co.jp/Products/LifeScience/fcm/products/sh800s/Cell sorter (BD FACSJazz)BD Bioscienceshttps://www.bdbiosciences.com/LightCycler 96 SystemRochehttps://diagnostics.roche.com/T100 Thermal cyclerBio-Radhttps://www.bio-rad.com/Trans-blot SD semi-dry transfer cellBio-Radhttps://www.bio-rad.com/Lumino Graph Ⅰ CMOSAttohttps://www.atto.co.jp/products/imaging_analysis/Plate reader (TECAN Infinite200PRO)Tecanhttps://www.tecan.com/Plate reader (MULTISKAN FC)Thermo Fisher ScientificCat#51119000SZ61 Stereo MicroscopeEvidenthttps://evidentscientific.com/CKX53 Cell Culture MicroscopeEvidenthttps://evidentscientific.com/CO2 incubatorPhcbihttps://www.phchd.com/Qubit 4 FluorometerThermo Fisher ScientificCat#Q33238Countess 3 FL Automated Cell CounterThermo Fisher ScientificCat#AMQAF2000Amersham Hybond P PVDF 0.2CytivaCat#10600021PC-100 PullerNarishigehttps://products.narishige-group.com/MF3 MicroforgeNarishigehttps://products.narishige-group.com/EG-45 MicrogrinderNarishigehttps://products.narishige-group.com/GD-1 grass capillary with filamentNarishigehttps://products.narishige-group.com/P-008 Egg incubatorShowa Furankihttp://www.showafuranki.com/PTFE membraneKokugohttps://enet.kokugo.shop/Plastic wrapAsahi Kaseihttps://www.asahi-kasei.co.jp/saran/scotch tape3Mhttps://www.scotchbrand.com/3M/ Experimental model and study participant details Chickens and eggs Fertilized chicken eggs used for cell cultures were obtained from the Avian Bioscience Research Center, Nagoya University. Host eggs (White Leghorn) used for PGC transplantation experiments were purchased from the Takeuchi Hatchery (Nara, Japan). All animal experiments were performed in accordance with the ethical guidelines and with the approval of the Animal Experimentation Committee of Nagoya University (A210437-002, A220054-003, A230041-003, A240027-003, and A250020-003). PGC culture medium PGCs were cultured using a previously reported method with some modifications.1 The basal medium, Avian KO-DMEM basal medium (250 mOsm·kg-1, 12.0 mM glucose, and CaCl2-free) was custom-ordered from Thermo Fisher Scientific. The complete medium was supplemented with the following: 1× B-27 minus vitamin A (Thermo Fisher Scientific), 1× NEAA (Thermo Fisher Scientific), 1× nucleosides (Merck), 1× monothioglycerol (Fujifilm), 2.0 mM GlutaMAX (Thermo Fisher Scientific), 1.2 mM pyruvate (Thermo Fisher Scientific), 0.2% chicken serum (Thermo Fisher Scientific), 1× penicillin-streptomycin (Thermo Fisher Scientific), 0.2% ovalbumin (Merck), 0.2% sodium heparin (Merck), 10 μg·mL-1 ovotransferrin (Merck), 4 ng·mL-1 FGF2 (R&D Systems), and 25 ng·mL-1 Activin A (PeproTech). Establishment of cultured PGC lines To establish chicken cultured PGC lines, 1-2 μL of blood was collected from individual HH St.14-16 embryos and seeded onto 96-well plates (WATSON) containing 200 μL of PGC culture medium. Half of the medium was replaced every 2 or 3 days. Once the total cell count reached approximately 1×104 cells, cells were transferred to 24-well plates (IWAKI). Lines that successfully expanded to 2–3×105 cells were considered to be established. These established lines were then cryopreserved using CELLBANKER 2 (Takara Bio), stored in liquid nitrogen, and used in subsequent experiments. Sex determination The sex of PGCs and embryos was identified as previously reported.83 Briefly, genomic DNA was extracted using the Easy DNA Extraction Kit version 2 (Kaneka). PCR was performed using KOD Fx Neo (Toyobo) under the following conditions: initial denaturation at 95°C for 60 s, followed by 10 cycles of 98°C for 10 s, 60°C for 30 s (with a -1°C touchdown per cycle), and 68°C for 30 s, followed by 30 cycles of 98°C for 10 s, 50°C for 30 s, and 68°C for 30 s. The primers used are listed in Table S16. Embryo transplantation of cultured PGCs and confirmation of germline transmission The PGC lines established from the M/O, GSP and GSN/1 strains were used to confirm germline transmission. Regarding the transplantation of cultured PGCs, a 0.8-cm window was opened in the eggshell of host embryos incubated for 52 hr, and blood was collected using a glass capillary. After confirming the sex of the host embryos using blood samples, 1×104 PGCs were transplanted into the blood of sex-matched host embryos. The window was sealed with Scotch Ultra Transparent Tape (3M), and the embryos were incubated until hatching. To confirm germline transmission, the hatched germline chimeric chicks were raised to sexual maturity. Chimeric hens, transplanted with PGC lines derived from the GSP strain, were mated with GSP roosters. The fertilized eggs obtained from these hens were incubated, and germline transmission was confirmed by the plumage color of the hatched chicks. Similarly, chimeric hens transplanted with GSN/1-derived PGCs were mated with M/O roosters. The fertilized eggs obtained from these hens were incubated for 2 days and then dissected for tissue collection. Genomic DNA was extracted using a cell lysis buffer (50 mM KCl (Fujifilm), 10 mM Tris-HCl (pH 8.3) (Nacalai), 2.5 mM MgCl2 (Fujifilm), 0.45% NP-40 (Nacalai), 0.45% Tween-20 (Fujifilm), and 200 μg·mL-1 proteinase K (Nippongene)) and incubated at 56°C overnight. The Fayoumi breed-specific deletion at the SOX10 loci84 was detected by PCR. PCR was performed using KOD Fx Neo following the cycle conditions and primers previously reported.84 Regarding chimeric roosters transplanted with Cas9-mCherry transgenic PGC lines established from the M/O strain, genomic DNA was purified from sperm after sexual maturity using the DNeasy Blood & Tissue Kit (Qiagen). The integration rate of the transgene in the sperm was quantified by qPCR. Roosters exhibiting high transmission efficiency were selected and mated with White Leghorn hens. Genomic DNA was purified from the hatched chicks as described above. The presence of the transgene was confirmed by PCR using primers specific for Cas9 or mCherry. PCR was performed with KOD Fx Neo under the following conditions: initial denaturation at 94°C for 2 min, followed by 35 cycles of 98°C for 10 s, 72°C for 30 s, and 68°C for 60 s. The primers used are listed in Table S16. Purification of blood-circulating PGCs To isolate circulating PGCs, embryonic blood was collected from HH St.14-16 M/O strain embryos and incubated with 10 μL of a BV421-labeled anti-SSEA-1 antibody (BD Biosciences, 562705) on ice for 1 hr in PBS(–) supplemented with 1% FBS. After washing with PBS(–), SSEA-1-positive cells were collected using a cell sorter (FACSJazz, BD Biosciences, or SH800S, Sony) and subjected to a qRT-PCR analysis. Preparation of CEFs CEFs were prepared from 9-day-old M/O strain embryos. After removing the head, limbs, and internal organs, the remaining tissues were minced and digested in a 0.1% trypsin-EDTA solution (Thermo Fisher Scientific). Dissociated cells were filtered through a 100-μm cell strainer and seeded onto 10-cm dishes (IWAKI) with DMEM high glucose (Fujifilm) supplemented with 10% FBS (Merck) and 1× penicillin-streptomycin. After 2-3 passages, cells were used in RNA-seq experiments. Method details qPCR Total RNA was extracted using the ReliaPrep RNA Miniprep System (Promega), and cDNA was synthesized using the ReverTra Ace qPCR RT Master Mix (Toyobo). qPCR was performed on a LightCycler 96 System (Roche) using THUNDERBIRD Next SYBR qPCR Mix (Toyobo) under the following conditions: at 95°C for 60 s, followed by 40 cycles of 95°C for 3 s, 60°C for 10 s, and 72°C for 30 s. Relative gene expression levels were calculated using the 2-ΔΔCt method, with GAPDH being used as an internal control for normalization. The primers used in the present study are listed in Table S16. RNA-seq data acquisition and mapping to the genome The RNA-seq analysis was performed using male and female PGC lines established from the single embryos of four strains (M/O, GSN/1, GSP, and PNP), CRISPRi-transduced M/O strain cultured PGCs, and CEFs. Sequencing libraries were prepared using the NEBNext Poly(A) mRNA Magnetic Isolation Module and the NEBNext Ultra II Directional RNA Library Prep Kit (New England Biolabs). Sequencing was performed on an Illumina NovaSeq 6000 or BGI DNBSEQ platform with 150-bp paired-end reads. The quality of raw reads was assessed using the fastp(v0.23.2),73 and low-quality bases and adapter sequences were trimmed under default parameters. The trimmed reads were then mapped to the chicken reference genome (GRCg7b, Ensembl release 109) using the HISAT2 (v2.2.1)74 with default parameters. The resulting SAM files were converted to the BAM format using the Samtools (v1.11).75 Additionally, publicly available RNA-seq data from embryonic PGCs36 were obtained from the NCBI SRA database and processed using the same pipeline as that described above. Bioinformatical analyses The number of reads mapped to each gene was counted using featureCounts (v2.0.1).76 Raw read counts were filtered to exclude low-count genes and were normalized using default parameters. In addition to the default count analysis, strand-specific read counting was performed using the -s option where appropriate. The DEG analysis was conducted using edgeR (v3.40.2).77 The GO analysis was performed using the g:Profiler online tool,79 and the KEGG pathway enrichment analysis was performed using clusterProfiler (v4.18.4).80 Transcripts per million (TPM) values for each transcript were calculated using the TPMCalculator (v0.0.3).78 Venn and UpSet plots were generated using the intervene online tool.82 The consensus motif analysis of the Soprano LTR was performed using the MEME suite online tool.43 The transcription factor-binding site prediction analysis was conducted using the JASPAR online tool46 with the human and mouse CORE transcription factor collection under default parameters. ENS-1/ERNI knockout and cell growth analysis The Cas9 and sgRNA expression vectors were derived from a modified pX330 plasmid (originally Addgene #64324),72 in which the mCherry gene was replaced with a puromycin-resistance gene (pX330_CBH::spCas9-T2A-PuroR-pA_mU6::sgRNA). To generate knockout constructs for ENS-1/ERNI (#1–#3), the plasmid was digested with BbsI-HF (NEB) and ligated with pre-annealed sgRNA spacer oligos. To evaluate the cleavage efficiency of sgENS-1/ERNI #1–#3, 10 μg of each knockout vector was co-transfected with 5 μg of pcDNA4_CMV::EGFP-pA into 1 × 106 PGCs. After 48 hr, EGFP-positive cells were isolated using a cell sorter, and genomic DNA was extracted using the DNeasy Blood & Tissue Kit. The genomic regions flanking the target sites were amplified using KOD One (Toyobo) under the following conditions: 95°C for 2 min, followed by 35 cycles of 98°C for 10 s, 60°C for 10 s, and 68°C for 20 s. Primers used for PCR are listed in Table S16. The resulting amplicons were analyzed by Sanger sequencing, and indel frequencies were calculated using the CRISPR-ICE online tool.81 In the cell growth analysis, 1×106 cultured PGCs were transfected with 10 μg of the knockout vectors. After a 24-hr culture, transfected cells were selected with 1 μg·mL-1 puromycin (Fujifilm) for an additional 24 hr. Dead cells were then removed using the Viahance Dead Cell Removal Kit (BioPal). Surviving PGCs were counted, and 2×104 cells were re-seeded into 48-well plates (IWAKI). Cell numbers were monitored at the indicated time points using the Countess 3 Automated Cell Counter (Thermo Fisher Scientific). CRISPRi The dCas9-KRAB-MeCP2 sequence was amplified from the Addgene #110821 plasmid42 using KOD One (Toyobo) and cloned into a piggyBac vector containing a blasticidin S-resistance gene via Gibson assembly cloning using the NEBuilder HiFi DNA Assembly Master Mix to make pPV_CAG::dCas9-KRAB-MeCP2-pA_EF1α::BsdR-pA. This plasmid was co-transfected with a piggyBac transposase expression plasmid into M/O strain cultured PGCs using Lipofectamine 2000. Stably transfected PGCs were selected with 10 μg·mL-1 blasticidin S (Fujifilm) for two weeks. Regarding in vitro-synthesized sgRNA transfection, 20 pmol of Alt-R CRISPR-Cas9 sgRNA (IDT) was transfected into 1×105 CRISPRi PGCs using Lipofectamine RNAiMAX (Thermo Fisher Scientific). After a 24-hr culture, cells were harvested for further analyses. To construct 3× sgRNA expression plasmids, each sgRNA spacer sequence was first cloned into the pPV_ mU6::sgRNA_ EF1α::EGFP (or mCherry)-IRES-PuroR-pA plasmid. mU6::sgRNA cassettes were then amplified using KOD One and assembled into the final constructs, pPV_3×(mU6::sgSoprano)_EF1α::EGFP-IRES-PuroR-pA and pPV_3×(mU6::sgOVA)_EF1α::mCherry-IRES-PuroR-pA, using the NEBuilder HiFi DNA Assembly Master Mix. Regarding transfection, 10 μg of these plasmids was introduced into 1×106 CRISPRi PGCs using Lipofectamine 2000. After 48 hr, EGFP- or mCherry-positive cells were collected using a cell sorter and subjected to further analyses. ERNI rescue experiments ERNI cDNA was amplified from an M/O strain PGC line using KOD One. The amplified fragment was cloned into the pcDNA4_CMV::EGFP-pA backbone, replacing the EGFP gene via Gibson assembly using the NEBuilder HiFi DNA Assembly Master Mix to generate the pcDNA4_CMV::ERNI-pA expression plasmid. Regarding transfection, 1×106 CRISPRi PGCs were transfected with 5 μg of the sgRNA expression plasmid (pPV_3×(mU6::sgSoprano)_EF1α::EGFP-IRES-PuroR-pA or pPV_3×(mU6::sgOVA)_EF1α::mCherry-IRES-PuroR-pA) and 5 μg of either pcDNA4_CMV::ERNI-pA or pcDNA4_CMV::EGFP-pA using Lipofectamine 2000. After a 48-hr culture, EGFP- or mCherry-positive cells were isolated using a cell sorter and subjected to further analyses. siRNA treatment DsiRNAs targeting ENS-1/ERNI (listed in Table S16) and a negative control DsiRNA were purchased from IDT. A total of 20 pmol of each DsiRNA was transfected into 1×105 of cultured PGCs (M/O or GSP strain) using Lipofectamine RNAiMAX. PGCs were then cultured for 48 hr and subjected to further analyses. Luciferase assay The cDNAs of NANOG and PRDM1 were amplified from M/O strain blastodermal cells using KOD Fx Neo and cloned into a pcDNA4_CMV::EGFP-pA vector by restriction enzyme digestion and ligation to make pcDNA4_CMV::EGFP-NANOG-pA or pcDNA4_CMV::EGFP-PRDM1-pA, respectively. Soprano sequences were amplified from the genomic DNA of M/O strain cultured PGCs by KOD One (Toyobo) and cloned into the pNL1.1[Nluc] vector (Promega) by Gibson assembly cloning using the NEBuilder HiFi DNA Assembly Master Mix to make pNL1.1_Soprano::Nluc-pA. Soprano deletion and point mutants were made from these vectors by inverse PCR using KOD One. In the reporter assay, 100 ng of each reporter plasmid and 10 ng of the pGL4.54[luc2/TK] firefly luciferase control plasmid were co-transfected into 1.5×104 cultured PGCs using Lipofectamine 2000, and cells were then seeded onto 96-well plates. Regarding DF-1 cells, 1.5×104 cells were seeded onto 96-well plates one day before transfection, and the same amount of the vector was transfected using Lipofectamine 3000 (Thermo Fisher Scientific). To investigate the effects of transcription factors, 100 ng of the respective expression vectors was co-transfected with the luciferase reporter vectors. After a 24-hr incubation, luciferase activities were measured using the Nano-Glo Dual-Luciferase reporter assay system (Promega) on a TECAN Infinite 200 PRO (Tecan) microplate reader. Inhibition of activin A and FGF2 signaling Cultured M/O strain PGCs was seeded onto fresh PGC culture medium containing 1 μM of the specific inhibitor A83-01 (Fujifilm) or PD0325901(Fujifilm)) or a vehicle (DMSO (Fujifilm), 0.15%). Cells were then incubated for the indicated periods before being subjected to further analyses. Cell cycle assay In the cell cycle assay, 10 μg of either the pPV_3×(mU6::sgSoprano)_EF1α::EGFP-IRES-PuroR-pA or pPV_3×(mU6::sgOVA)_EF1α::mCherry-IRES-PuroR-pA plasmid was introduced into 1×106 CRISPRi PGCs using Lipofectamine 2000. After a 48-hr culture, EGFP- or mCherry-positive cells were collected using a cell sorter. Sorted cells were stained with Cell Cycle Assay Solution Blue (Dojindo) at 37°C for 15 min and subsequently re-analyzed using a cell sorter. To investigate the effects of DNA damage inducers on the cell cycle, CPT (Fujifilm) was applied at a predetermined dose for 1 hr, starting one day after sgRNA expression plasmid transfection. After washing with PBS(–), cells were cultured for a further 24 hr prior to the cell cycle analysis. Cell proliferation assay In the cell proliferation assay, 10 μg of either the pPV_3×(mU6::sgSoprano)_EF1α::EGFP-IRES-PuroR-pA or pPV_3×(mU6::sgOVA)_EF1α::mCherry-IRES-PuroR-pA plasmid was introduced into 1×106 CRISPRi PGCs using Lipofectamine 2000. After a 24-hr culture, EGFP- or mCherry-positive cells were collected using a cell sorter. Sorted cells were treated with CPT at a predetermined dose for 1 hr. After washing with fresh medium, cells were counted using a Countess 3 Automated Cell Counter, and 2×104 cells were re-seeded into a 96-well plate. After 3 days of further cultivation, cells were stained using the Cell Counting Kit-8 (Dojindo), and the absorbance of formazan dye was measured using a plate reader (MULTISKAN FC, Thermo). JC-1 assay The pPV_3×(mU6::sgSoprano)_EF1α::BFP-WPRE-pA and pPV_3×(mU6::sgOVA)_EF1α::BFP-WPRE-pA plasmids were generated from the corresponding EGFP- or mCherry-IRES-PuroR-pA vectors by replacing the reporter/selection cassette with BFP-WPRE-pA via PCR amplification using KOD One and Gibson assembly using the NEBuilder HiFi DNA Assembly Master Mix. In the JC-1 assay, 10 μg of these plasmids was introduced into 1×106 CRISPRi PGCs using Lipofectamine 2000. After a 24-hr culture, cells were treated with a predetermined concentration of CPT for 5 hr. Following the treatment, cells were stained with the MitoPT JC-1 Assay kit (ImmunoChemistry Technologies). Apoptotic cells within the BFP-positive population were subsequently analyzed by flow cytometry. Soprano LTR CRISPRi PGC transplantation Regarding sgRNA expression plasmid transfection, 8 μg of either pPV_3×(mU6::sgSoprano)_EF1α::EGFP-IRES-PuroR-pA or pPV_3×(mU6::sgOVA)_EF1α::mCherry-IRES-PuroR-pA and 2 μg of the piggyBac transposase expression plasmid were co-transfected into 1×106 CRISPRi-expressing PGCs using Lipofectamine 2000. After a 24-hr culture, EGFP- or mCherry-positive cells were collected using a cell sorter. A total of 2-3×103 sorted cells were injected into the subgerminal cavity of EG&K St.X blastoderms or the blood vessels of HH St.14-16 embryos. The eggshell was sealed with a PTFE membrane (Kokugo) and plastic wrap (Asahi KASEI) for blastoderms or scotch tape (3M) for HH St.14-16 embryos. Injected embryos were incubated with the sealed side facing down (for blastoderms) or up (for HH St.14-16 embryos) at 38°C under 60% humidity with a rocking angle of 90° (blastoderms) or 30° (HH St.14-16 embryos) every hour. After 3.5 days, the embryos were sacrificed and the embryonic genital ridges or gonads were isolated. The tissues were dissociated by TrypLE Express (Thermo Fisher Scientific), filtered through 100-μm cell strainers, and stained with 3 μL of a BV421-labeled anti-SSEA-1 antibody (BD Biosciences, 562705) on ice for 1 hr in PBS(–) containing 1% FBS. The ratio of SSEA-1- and EGFP- or mCherry-positive cells was analyzed using flow cytometry. Western blotting A total of 1×106 cells was lysed in 100 μL of SDS lysis buffer (62.5 mM Tris-HCl (pH6.8) (Nacalai), 1.5% SDS (Fujifilm), 8.5% glycerol (Fujifilm), 0.67% 2-mercaptoethanol (Fujifilm), and 0.005% bromophenol blue (Fujifilm)). Equal volumes of protein samples were separated by 10% SDS-PAGE and transferred onto PVDF membranes (Cytiva) using a semi-dry transfer system (Bio-rad). The membranes were blocked with PVDF Blocking Reagent for Can Get Signal (Toyobo) at room temperature for 1 hr, followed by an overnight incubation at 4°C with the following primary antibodies: anti-phospho-SMAD2 (1:1,000, Cell Signaling Technology) or anti-phospho-p44/42 MAPK (1:1,000, Cell Signaling Technology). After washing three times with TBS-T (50 mM Tris-HCl (pH7.6), 150 mM NaCl (Fujifilm), and 0.05% Tween20 (Fujifilm)), the membranes were incubated with HRP-conjugated secondary antibodies (1:5,000, MBL International) at room temperature for 1 hr. Protein bands were visualized using Western BLoT Hyper HRP Substrate (Takara) and captured with a LuminoGraph I CMOS imaging system (Atto). To ensure equal loading, the membranes were stripped with 0.2 M NaOH (Fujifilm) and re-probed for β-actin using an anti-β-actin antibody (1:5,000, MBL International). A densitometric analysis was performed using CS Analyzer 4 (Atto) software, and the levels of the target proteins were normalized to those of β-actin. IF and flow cytometry CRISPRi PGCs were transfected with plasmids for the detection of either ENS-1/ERNI (pPV_3×(mU6::sgSoprano)_EF1α::EGFP-IRES-PuroR-pA and pPV_3×(mU6::sgOVA)_EF1α::mCherry-IRES-PuroR-pA) or CDH7 (pPV_3×(mU6::sgSoprano)_EF1α::BFP-WPRE-pA and pPV_3×(mU6::sgOVA)_EF1α::BFP-WPRE-pA). After a 3-day incubation, transfected cells were collected using a cell sorter as described above. These cells were fixed with ice-cold methanol (Fujifilm) at 4°C for 20 min. After washing with PBS containing 0.05% Triton X-100 (PBS-T), cells were incubated in blocking buffer (PBS-T supplemented with 5% FBS) at room temperature for 1 hr. Subsequently, cells were incubated at room temperature for 1 hr with the primary antibodies against ENS-1/ERNI (1:100, Covalab) or CDH7 (1:100, Abcam) diluted in blocking buffer. Following two washes with blocking buffer, cells were incubated with Alexa Fluor 647- or 488-conjugated secondary antibodies (1:200, Thermo Fisher Scientific) at room temperature for 1 hr in the dark. After two final washes with blocking buffer, fluorescence intensity was analyzed using flow cytometry. Quantification and statistical analysis Statistical analyses were performed using GraphPad Prism 9. Data are presented as the mean ± standard deviation (SD) in bar and line graphs, and as individual values with the median in dot plots. P-values < 0.05 were considered to be significant, and were labeled as follows: ∗p<0.05, ∗∗p<0.01. ∗∗∗p<0.001, ∗∗∗∗p<0.0001. The specific statistical tests used are specified in the corresponding figure legends. Detailed statistics are summarized in Table S17.